Polymorphism in the Promoter Region of the Insulin-like Growth Factor I Gene Is Related to Carotid Intima-Media Thickness and Aortic Pulse Wave Velocity in Subjects With Hypertension
- 1 July 2003
- journal article
- Published by Wolters Kluwer Health in Stroke
- Vol. 34 (7) , 1623-1627
- https://doi.org/10.1161/01.str.0000076013.00240.b0
Abstract
Background and Purpose— Low circulating levels of insulin-like growth factor I (IGF-I) have been associated with an increased risk for atherosclerosis. Absence of the 192-bp (wild-type) allele in the promoter region of the IGF-I gene has been associated with low circulating IGF-I levels. We examined the role of this polymorphism in relation to blood pressure and 2 early markers of atherosclerosis: carotid intima-media thickness (IMT) and aortic pulse wave velocity (PWV). Methods— A total of 5132 subjects of the Rotterdam Study, aged 55 to 75 years, were included in this study. In 3769 subjects who did not use blood pressure–lowering medication, the association between the IGF-I polymorphism and blood pressure was examined. In the total population, and in 3484 normotensive subjects, 1648 hypertensive and 462 untreated hypertensive subjects, the association between this polymorphism and IMT and PWV was examined. Results— Mean systolic and diastolic blood pressure did not differ between genotypes. In hypertensive subjects IMT was significantly increased in noncarriers of the 192-bp allele (0.83 mm) compared with heterozygous or homozygous carriers (0.80 mm) ( P =0.04). PWV was also significantly higher in hypertensive subjects who were noncarriers of the 192-bp allele (14.3 m/s) compared with heterozygous (14.1 m/s) or homozygous carriers (13.7 m/s) ( P =0.02). Findings were more pronounced in hypertensive subjects without medication use. In normotensive subjects, no association between this polymorphism, IMT, and PWV was observed. Conclusions— Our study suggests that hypertensive subjects who have low IGF-I levels because of a genetic polymorphism in the IGF-I gene are at increased risk of developing atherosclerosis.Keywords
This publication has 18 references indexed in Scilit:
- Increase of adhesion molecules, fibrinogen, type‐1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacementClinical Endocrinology, 2000
- Growth hormone replacement therapy in adults with growth hormone deficiency improves vascular reactivityClinical Endocrinology, 1999
- Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study.Journal of Clinical Investigation, 1996
- Insulin-like growth factor-1 and angiographically documented coronary artery diseaseThe American Journal of Cardiology, 1996
- Nitric oxide— biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosisAtherosclerosis, 1995
- Insulin-like growth factor I and its binding proteins in the cardiovascular systemCardiovascular Research, 1995
- Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cellsKidney International, 1994
- Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adultsThe Lancet, 1992
- Regulation of insulin-like growth factor I messenger RNA levels in vascular smooth muscle cells.Hypertension, 1991
- Cholesterol determinations. a comparative study of methods with special reference to enzymatic proceduresClinica Chimica Acta; International Journal of Clinical Chemistry, 1977